BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 23893190)

  • 1. Efficacy of sublingual specific immunotherapy on allergic asthma and rhinitis in children's real life.
    De Castro G; Zicari AM; Indinnimeo L; Tancredi G; di Coste A; Occasi F; Castagna G; Giancane G; Duse M
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2225-31. PubMed ID: 23893190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of sublingual immunotherapy with Dermatophagoides farinae drops in preschool and school-age children with allergic asthma and allergic rhinitis].
    Chen S; Wang L; Liao F; Zeng X; Xing QB; Chen B; Lin XZ
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):831-5. PubMed ID: 24484557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy in children with allergic polysensitization.
    Ciprandi G; Cadario G; Di Gioacchino GM; Gangemi S; Gasparini A; Isola S; Marengo F; Minelli S; Ricciardi L; Ridolo E; Pravettoni V; Valle C; Verini M; Zambito M; Incorvaia C; Puccinelli P; Scurati S; Frati F; Simonetta M
    Allergy Asthma Proc; 2010; 31(3):227-31. PubMed ID: 20615323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of non-grass pollens respiratory allergies in Italy and effects of specific sublingual immunotherapy: The Rainbow Trial, a multicentre 3-year prospective observational study.
    Milani M; Pecora S;
    Eur Ann Allergy Clin Immunol; 2011 Aug; 43(4):111-6. PubMed ID: 21980798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of sublingual immunotherapy of allergic rhinitis in children between 4 and 5 years age group and 11 and 12 years age group].
    Cui L; Wang ZN; Xu ZQ; Xia ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 48(1):17-21. PubMed ID: 23656810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more.
    Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
    Allergy; 2004 Nov; 59(11):1205-10. PubMed ID: 15461603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety and tolerability of sublingual monomeric allergoid in tablets given without up-dosing to pediatric patients with allergic rhinitis and/or asthma due to grass pollen.
    Agostinis F; Foglia C; Bruno ME; Falagiani P
    Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):177-80. PubMed ID: 20128231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.
    Gammeri E; Arena A; D'Anneo R; La Grutta S
    Allergol Immunopathol (Madr); 2005; 33(4):221-3. PubMed ID: 16045861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy.
    Lin SY; Leatherman B
    Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
    Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
    J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.
    Rossi RE; Monasterolo G
    Int J Immunopathol Pharmacol; 2005; 18(2):277-85. PubMed ID: 15888250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the route of immunotherapy administration: an 18-year survey in pediatric patients with allergic rhinitis and asthma.
    Pajno GB; Caminiti L; Passalacqua G
    Allergy Asthma Proc; 2013; 34(6):523-6. PubMed ID: 24169060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy in polysensitized allergic patients with rhinitis and/or asthma: allergist choices and treatment efficacy.
    Ciprandi G; Cadario G; Di Gioacchino M; Gangemi S; Minelli M; Ridolo E; Valle C; Verini M; Boccardo R; Incorvaia C; Puccinelli P; Scurati S; Frati F
    J Biol Regul Homeost Agents; 2009; 23(3):165-71. PubMed ID: 19828093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis.
    Sieber J; Köberlein J; Mösges R
    Curr Med Res Opin; 2010 Apr; 26(4):925-32. PubMed ID: 20163297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.